Security record · archived quarter
AVIR
Atea Pharmaceuticals, Inc. · Healthcare · Biotechnology
12Tracked holders
0Δ holders
25.41MShares held
$91.49MReported value
+1New positions
−1Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +0.1% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2025
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 62 | -4 | 39.30M | $182.78M | +3 | −7 |
| Q1 2026 | 68 | +5 | 39.11M | $209.92M | +8 | −3 |
| Q4 2025 | 63 | +1 | 37.55M | $134.03M | +1 | — |
| Q3 2025 | 17 | +2 | 27.75M | $80.49M | +2 | — |
| Q2 2025 | 12 | 0 | 25.41M | $91.49M | +1 | −1 |
| Q1 2025 | 9 | -1 | 6.11M | $18.26M | — | −1 |
| Q4 2024 | 10 | +1 | 6.07M | $20.35M | +2 | −1 |
| Q3 2024 | 8 | 0 | 4.57M | $15.30M | +1 | −1 |
| Q2 2024 | 8 | — | 4.70M | $15.57M | — | — |
Who holds it · Q2 2025
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 8.67M | — | $31.21M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (passive) | 8.67M | — | $31.21M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passive) | 8.67M | — | $31.21M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passive) | 8.67M | — | $31.21M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passive) | 8.67M | — | $31.21M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passive) | 8.67M | — | $31.21M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passive) | 8.67M | — | $31.21M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passive) | 8.67M | — | $31.21M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passive) | 8.67M | — | $31.21M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passive) | 8.67M | — | $31.21M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Fidelity (FMR) ✦ | 5.72M | — | $20.59M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Fidelity (FMR) ✦ | 5.72M | — | $20.59M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Fidelity (FMR) ✦ | 5.72M | — | $20.59M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | The Vanguard Group ✦ (passive) | 4.89M | — | $17.59M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | The Vanguard Group ✦ (passive) | 4.89M | — | $17.59M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | The Vanguard Group ✦ (passive) | 4.89M | — | $17.59M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Geode Capital Management ✦ (passive) | 1.93M | -2.6% | $6.93M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 18 | Geode Capital Management ✦ (passive) | 1.93M | -2.6% | $6.93M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 19 | State Street Global Advisors ✦ (passive) | 1.78M | +0.3% | $6.40M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | Renaissance Technologies ✦ | 1.23M | -3.5% | $4.44M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 21 | Two Sigma Investments ✦ | 366.61K | +45.6% | $1.32M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 22 | Wellington Management ✦ | 359.45K | +18.0% | $1.29M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 23 | Wellington Management ✦ | 359.45K | +18.0% | $1.29M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | Wellington Management ✦ | 359.45K | +18.0% | $1.29M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | D. E. Shaw & Co. ✦ | 195.85K | -43.2% | $705,067 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 26 | D. E. Shaw & Co. ✦ | 195.85K | -43.2% | $705,067 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 27 | Millennium Management ✦ | 174.49K | +127.9% | $628,164 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 28 | T. Rowe Price ✦ | 79.91K | 0.0% | $288,000 | 0.0% | Held | 5 | SEC ↗ |
| 29 | Marshall Wace ✦ | 24.87K | New | $89,521 | 0.0% | New | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Marshall Wace | $89,521 | 0.0% |
Exited
| Citadel Advisors | $65,756 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 126 holders, 59.16M shares, $308.71M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2025 ·
Methodology ·
Get this via the API